Pharmacogenetics and Pharmacogenomics. J. Steven Leeder PharmD, PhD Pediatric Clinics of North America - Volume 48, Issue 3 (June 2001). DOI: 10.1016/S0031-3955(05)70338-2.
T. Lynch, A. Price, The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects., in Am Fam Physician, vol. 76, n. 3, agosto 2007, pp. 391-6, PMID17708140.
K. Droll, K. Bruce-Mensah; SV. Otton; A. Gaedigk; EM. Sellers; RF. Tyndale, Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians., in Pharmacogenetics, vol. 8, n. 4, Ago 1998, pp. 325-33, PMID9731719.
RA. McLellan, M. Oscarson; J. Seidegård; DA. Evans; M. Ingelman-Sundberg, Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians., in Pharmacogenetics, vol. 7, n. 3, giugno 1997, pp. 187-91, PMID9241658.
W. Zhang, Y. Ramamoorthy; RF. Tyndale; EM. Sellers, Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro., in Drug Metab Dispos, vol. 31, n. 6, giugno 2003, pp. 768-72, PMID12756210.
N. He, WQ. Zhang; D. Shockley; T. Edeki, Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes., in Eur J Clin Pharmacol, vol. 57, n. 12, febbraio 2002, pp. 847-51, PMID11936702.